CASP9 and inflammatory bowel disease: Our observations are consistent with the results obtained by Neubauer et al. They assessed CASP-9 concentration in peripheral blood lymphocytes of patients with IBD by immunoenzymatic method and showed significantly lower concentrations of CASP-9 in patients with active IBD compared to the control group (Neubauer et al. 2018).